The present study showed that E-cadherin (as an epithelial marker) is down-regulated whereas concomitantly N-cadherin, vimentin, and MMP-9 (as mesenchymal markers) are up-regulated in colorectal cancer. Here, CDH2 is linked to colorectal cancer.